No class action status in CA Vioxx lawsuit
Pharma Compliance Alert, May 13, 2009
Los Angeles Superior Court Judge Victoria G. Chaney denied class action status to plaintiffs seeking to sue Merck for its withdrawn painkiller Vioxx.
Chaney said in her ruling that trying plaintiffs’ claims would require an examination of each proposed class member’s medical needs and history, which Merck successfully argued would be unfair, according to a company statement.
Read more about Chaney's decision in the Vioxx lawsuit.
Related Products
Most Popular
- Articles
-
- HIPAA Q&A: Flu shot requirement for hospital employees
- HealthDataInsights posts new issues for medical necessity claims
- Q&A: Incidental disclosures and patient privacy
- New FAQ posted on storing laryngoscope blades
- Sneak Peek: Effort underway to establish caseload benchmarks
- Tip: Perform your own internal investigation prior to government audit
- What does case-mix index mean to you?
- HIPAA 5010 deadline extended, but threat remains, says AMA
- HHS task force: Consider privacy, security with text messages
- Capturing all necessary codes for IUD insertion and removal can be challenging
- E-mailed
-
- What does case-mix index mean to you?
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- HHS task force: Consider privacy, security with text messages
- HIPAA Q&A: Flu shot requirement for hospital employees
- Tip: Correctly code bilateral pain management procedures
- Tip: Know the common bunionectomy procedure codes and how to use them
- Code changes should help ease the pain when coding for facet joint injections
- 2012 CPT code changes for ASCs: Shoulder and knee scopes and pain management
- Documentation and coding for toxic metabolic encephalopathy
- News and briefs: UA study links lack of empathy in residents to long shifts
- Searched
